- Previous Close
2.9500 - Open
2.7400 - Bid 2.2800 x 100
- Ask 2.3400 x 100
- Day's Range
2.2201 - 2.9300 - 52 Week Range
2.2201 - 316.8000 - Volume
626,824 - Avg. Volume
1,079,647 - Market Cap (intraday)
1.374M - Beta (5Y Monthly) 0.38
- PE Ratio (TTM)
-- - EPS (TTM)
-114.1900 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.
bluejaydx.comRecent News: BJDX
View More
Performance Overview: BJDX
Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BJDX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BJDX
View MoreValuation Measures
Market Cap
1.64M
Enterprise Value
-2.44M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.29
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-60.78%
Return on Equity (ttm)
-138.78%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-8.59M
Diluted EPS (ttm)
-114.1900
Balance Sheet and Cash Flow
Total Cash (mrq)
5.76M
Total Debt/Equity (mrq)
3.57%
Levered Free Cash Flow (ttm)
-6.78M
Research Analysis: BJDX
View MoreResearch Reports: BJDX
View MoreDaily – Vickers Top Insider Picks for 05/05/2022
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 05/04/2022
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 05/03/2022
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 05/02/2022
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.